Two Sigma Securities, LLC Xenetic Biosciences, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.31 - $0.73 $6,269 - $14,763	20,224 New	20,224 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $5.57 $8,238 - $77,779	13,964 New	13,964 $8,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.37 $12,354 - $19,233	-14,039 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.08 $17,829 - $29,201	14,039 New	14,039 $18,000
Q1 2021 May 17, 2021	SELL	$2.01 - $3.5 $64,342 - $112,038	-32,011 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.79 - $3.17 $25,288 - $101,474	32,011 New	32,011 $65,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.